EAGLE PHARMACEUTICALS INC's ticker is and the CUSIP is 269796958. A total of 4 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,000 | -95.9% | 4 | -95.1% | 0.00% | -100.0% |
| Q2 2020 | $388,000 | -81.3% | 81 | -82.0% | 0.00% | -75.0% |
| Q1 2020 | $2,070,000 | -6.8% | 450 | +21.6% | 0.00% | -20.0% |
| Q4 2019 | $2,222,000 | +169.3% | 370 | +153.4% | 0.01% | +150.0% |
| Q3 2019 | $825,000 | -41.9% | 146 | -42.7% | 0.00% | -50.0% |
| Q2 2019 | $1,419,000 | +151.2% | 255 | +127.7% | 0.00% | +100.0% |
| Q1 2019 | $565,000 | -56.6% | 112 | -65.3% | 0.00% | -50.0% |
| Q4 2018 | $1,301,000 | -55.9% | 323 | -24.2% | 0.00% | -55.6% |
| Q3 2018 | $2,953,000 | +153.5% | 426 | +176.6% | 0.01% | +80.0% |
| Q2 2018 | $1,165,000 | +3540.6% | 154 | +11.6% | 0.01% | +400.0% |
| Q1 2018 | $32,000 | -54.9% | 138 | -48.3% | 0.00% | -66.7% |
| Q4 2017 | $71,000 | +1.4% | 267 | +53.4% | 0.00% | 0.0% |
| Q3 2017 | $70,000 | +3400.0% | 174 | +1238.5% | 0.00% | – |
| Q2 2017 | $2,000 | -75.0% | 13 | -31.6% | 0.00% | – |
| Q1 2017 | $8,000 | -84.9% | 19 | -87.8% | 0.00% | -100.0% |
| Q4 2016 | $53,000 | +1666.7% | 156 | +100.0% | 0.00% | – |
| Q3 2016 | $3,000 | -93.9% | 78 | -73.1% | 0.00% | -100.0% |
| Q2 2016 | $49,000 | +96.0% | 290 | +900.0% | 0.00% | +50.0% |
| Q1 2016 | $25,000 | -44.4% | 29 | -35.6% | 0.00% | -50.0% |
| Q4 2015 | $45,000 | -27.4% | 45 | -8.2% | 0.00% | -20.0% |
| Q3 2015 | $62,000 | +100.0% | 49 | -38.8% | 0.01% | +66.7% |
| Q2 2015 | $31,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 19,700 | $794,000 | 0.01% |
| SIMPLEX TRADING, LLC | 323 | $1,301,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |